DelphX Announces Closing of Non-Brokered Unit Private Placement

Rhea-AI Summary

DelphX (OTCQB: DPXCF; TSXV: DELX) closed a non-brokered unit private placement announced Nov 27, 2025, issuing 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000. Each unit comprises one common share and one warrant.

Each warrant allows purchase of one common share at $0.07 for two years from issuance. Completion remains subject to TSX Venture Exchange approval. Securities are subject to a four-month plus one day hold period. DelphX intends to use net proceeds for working capital and corporate overhead.

Positive

• Gross proceeds C$112,000 raised for working capital
• Units include common share plus one warrant, offering structured investor incentive

Negative

• 2,800,000 warrants exercisable at $0.07 for two years create potential dilution
• Offering completion is subject to TSXV approval, so issuance is not final
• C$112,000 gross proceeds represent a relatively small funding amount

News Market Reaction – DPXCF

+8.14%

1 alert

+8.14% News Effect

On the day this news was published, DPXCF gained 8.14%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Units issued: 2,800,000 units Unit price: C$0.04 per unit Gross proceeds: C$112,000 +5 more

8 metrics

Units issued 2,800,000 units Non-brokered private placement closing on Dec 2, 2025

Unit price C$0.04 per unit Subscription price in this offering

Gross proceeds C$112,000 Total raised in this non-brokered placement

Warrant exercise price $0.07 per share Exercise price for each attached warrant

Warrant term 2 years Exercise period from date of issuance

Hold period 4 months plus 1 day Resale restriction on securities issued

Price change -7.81% Move prior to this news vs previous close

52-week range $0.0295–$0.1653 Current price at 52-week low; 82.15% below high

Market Reality Check

Price: $0.0285 Vol: Volume 45,000 vs 20-day a...

normal vol

$0.0285 Last Close

Volume Volume 45,000 vs 20-day average 39,489 (relative volume 1.14x). normal

Technical Price 0.0295 is trading below 200-day MA at 0.08 and at the 52-week low.

Peers on Argus

DPXCF was down 7.81% while key peers were mostly flat; only MATEF fell 3.93%, po...

DPXCF was down 7.81% while key peers were mostly flat; only MATEF fell 3.93%, pointing to a stock-specific reaction rather than a sector-wide move.

Historical Context

5 past events · Latest: Nov 14 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Nov 14	Private placement close	Neutral	-5.9%	Closed non-brokered placement of 1.2M units for C$60,000.
Nov 12	Private placement announce	Neutral	-2.9%	Announced intent for 1.2M-unit non-brokered private placement.
Oct 15	Warrant extension plan	Neutral	+0.0%	Planned extension of 3.48M warrants exercisable at $0.20.
Aug 22	Warrant extensions	Neutral	+25.7%	Sought to extend two warrant series totaling over 7.6M warrants.
Jul 31	Business update	Positive	-5.7%	Outlined new private placement marketing and crypto product initiatives.

Pattern Detected

Recent capital-structure news (warrant changes, private placements) often coincided with volatile and sometimes negative next-day moves, including on prior private placements.

Recent Company History

Over the last six months, DelphX issued multiple non-brokered private placements and adjusted existing warrants. Closings on Feb 21, Mar 21, and Nov 14, 2025 raised capital via units with attached warrants, while warrant extensions in August and October 2025 modified prior financing terms. A midsummer business update on Jul 31, 2025 outlined new revenue verticals. Today’s unit financing continues this pattern of small, structure-heavy capital raises.

Market Pulse Summary

The stock moved +8.1% in the session following this news. A strong positive reaction aligns with Del...

Analysis

The stock moved +8.1% in the session following this news. A strong positive reaction aligns with DelphX’s history of sharp moves around capital-structure news, where prior private placements saw average next-day moves of 11.28%. Investors would likely have focused on fresh working-capital funding of C$112,000 and the attached $0.07 warrants. However, the company’s position at the 52-week low and repeated small financings could still raise concerns about ongoing dilution risk.

Key Terms

non-brokered private placement, unit private placement, common share purchase warrant

3 terms

non-brokered private placement financial

"it has closed its non-brokered private placement previously announced"

A non-brokered private placement is when a company raises money by selling securities (such as shares or bonds) directly to a small group of chosen investors without using a broker or dealer as a middleman. For investors it matters because it can provide faster, lower-cost access to new investment opportunities but may bring higher risk, less liquidity and potential dilution of existing holdings compared with public offerings.

unit private placement financial

"closed its non-brokered unit private placement previously announced"

A unit private placement is a way a company raises money by selling bundles of securities—typically stock paired with a right to buy more shares later—to a small group of accredited investors rather than the public. It matters to investors because it brings cash for growth or debt relief but can dilute existing ownership and change future share value, much like a bakery selling a discounted combo that also includes a coupon for future purchases.

common share purchase warrant financial

"one common share ("Common Share") and one Common Share purchase warrant"

A common share purchase warrant is a tradable contract that gives its holder the right, but not the obligation, to buy a company’s common stock at a specified price within a set period. Think of it like a coupon for future shares: if the stock rises above the coupon price it can boost returns for the holder, but when used it increases the number of outstanding shares and can reduce each existing shareholder’s ownership and affect the company’s cash position.

AI-generated analysis. Not financial advice.

Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that it has closed its non-brokered private placement previously announced on November 27, 2025, issuing 2,800,000 units (the "Units") at a subscription price of C$0.04 per Unit, for gross proceeds of C$112,000 ("the Offering"). Each Unit consists of one common share ("Common Share") and one Common Share purchase warrant ("Warrant"). Each Warrant entitles the holder to purchase one Common Share at a price of $0.07, for a period of two years from the date of issuance.

Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.

DelphX intends to use the net proceeds from the Offering in connection with working capital/corporate overhead.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

• Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;

• Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com

George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276707

FAQ

What exactly did DelphX (DPXCF) issue in the December 2, 2025 private placement?

DelphX issued 2,800,000 units at C$0.04 each; each unit includes one common share and one warrant.

How large was the DelphX (DPXCF) financing closed Dec 2, 2025?

The offering raised gross proceeds of C$112,000.

What are the warrant terms from DelphX's Dec 2, 2025 placement (DPXCF)?

Each warrant entitles the holder to buy one common share at $0.07 for two years from issuance.

Is the DelphX (DPXCF) private placement final and tradable now?

Completion is subject to TSX Venture Exchange approval, and issued securities have a four-month-plus-one-day hold period.

How will DelphX (DPXCF) use the net proceeds from the offering?

DelphX intends to use net proceeds for working capital and corporate overhead.